Evidence map›Paper›PMID 33072178›Full record

ArticleInfectious agents and cancer2020

Design and feasibility of a novel program of cervical screening in Nigeria: self-sampled HPV testing paired with visual triage.

Kanan T Desai, Kayode O Ajenifuja, Adekunbiola Banjo, Clement A Adepiti, Akiva Novetsky, Cathy Sebag, Mark H Einstein, Temitope Oyinloye, Tamara R Litwin, Matt Horning and 17 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Infectious agents and cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06815939 (Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer), which is not on this map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06815939 narecruitingnot on this mapstarted 2025, after this paper: background citation

Validation of a Lab-free Low-cost Screening Test for Prevention of Cervical Cancer: Automated Visual Evaluation

TypeinterventionalSponsorDL AnalyticsRan2025 to 2026Enrolled10,000ConditionsHuman Papillomavirus (HPV), Cervical Intraepithelial Neoplasia, Uterine Cervical Neoplasms, Cervical CancersArmsHPV Test, EVA System, Visual Inspection with Acetic Acid (VIA), Automated Visual Evaluation (AVE), Image Capture with Mobile Phone
3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 8 institutions in 2 countries.

Kanan T Desai *Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, USA.
Kayode O Ajenifuja *Department of Obstetrics and Gynecology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria.
Adekunbiola BanjoLagos University Teaching Hospital, Lagos, Nigeria.
Clement A AdepitiDepartment of Obstetrics and Gynecology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria.
Akiva NovetskyRutgers New Jersey Medical School and Cancer Institute of New Jersey (CINJ), Newark, USA.
Cathy SebagHela Health, Tel Aviv, Israel.
Mark H EinsteinRutgers New Jersey Medical School and Cancer Institute of New Jersey (CINJ), Newark, USA.
Temitope OyinloyeDepartment of Obstetrics and Gynecology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria.
Tamara R LitwinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, USA.
Matt HorningGlobal Health Labs, Bellevue, USA.
Fatai Olatunde OlanrewajuDepartment of Obstetrics and Gynecology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria.
Mufutau Muphy OripelayeDepartment of Obstetrics and Gynecology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria.
Esther AfolabiDepartment of Obstetrics and Gynecology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria.
Oluwole O OdujokoDepartment of Obstetrics and Gynecology, Obafemi Awolowo University Teaching Hospital, Ile Ife, Nigeria.
Philip E CastleAlbert Einstein College of Medicine, New York City, USA.
Sameer AntaniNational Library of Medicine, NIH, Bethesda, USA.
Ben WilsonGlobal Health Labs, Bellevue, USA.
Liming HuGlobal Health Labs, Bellevue, USA.
Courosh MehanianGlobal Health Labs, Bellevue, USA.
Maria DemarcoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, USA.
Julia C GageDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, USA.
Zhiyun XueNational Library of Medicine, NIH, Bethesda, USA.
Leonard R LongNational Library of Medicine, NIH, Bethesda, USA.
Li CheungDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, USA.
Didem EgemenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, USA.
Nicolas WentzensenDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, USA.
Mark SchiffmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, Rockville, USA.ORCID 0000-0002-4625-2508
National Cancer Institute · USObafemi Awolowo University · NGBellevue Hospital Center · USUnited States National Library of Medicine · USRutgers, The State University of New Jersey · USAlbert Einstein College of Medicine · USLagos University Teaching Hospital · NGOak Ridge Associated Universities · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAccelerated global control of cervical cancer would require primary prevention with human papillomavirus (HPV) vaccination in addition to novel screening program strategies that are simple, inexpensive, and effective. We present the feasibility and outcome of a community-based HPV self-sampled screening program.

methodsIn Ile Ife, Nigeria, 9406 women aged 30-49 years collected vaginal self-samples, which were tested for HPV in the local study laboratory using Hybrid Capture-2 (HC2) (Qiagen). HPV-positive women were referred to the colposcopy clinic. Gynecologist colposcopic impression dictated immediate management; biopsies were taken when definite acetowhitening was present to produce a histopathologic reference standard of precancer (and to determine final clinical management). Retrospective linkage to the medical records identified 442 of 9406 women living with HIV (WLWH).

resultsWith self-sampling, it was possible to screen more than 100 women per day per clinic. Following an audio-visual presentation and in-person instructions, overall acceptability of self-sampling was very high (81.2% women preferring self-sampling over clinician collection). HPV positivity was found in 17.3% of women. Intensive follow-up contributed to 85.9% attendance at the colposcopy clinic. Of those referred, 8.2% were initially treated with thermal ablation and 5.6% with large loop excision of transformation zone (LLETZ). Full visibility of the squamocolumnar junction, necessary for optimal visual triage and ablation, declined from 68.5% at age 30 to 35.4% at age 49. CIN2+ and CIN3+ (CIN- Cervical intraepithelial neoplasia), including five cancers, were identified by histology in 5.9 and 3.2% of the HPV-positive women, respectively (0.9 and 0.5% of the total screening population), leading to additional treatment as indicated. The prevalences of HPV infection and CIN2+ were substantially higher (40.5 and 2.5%, respectively) among WLWH. Colposcopic impression led to over- and under-treatment compared to the histopathology reference standard.

conclusionA cervical cancer screening program using self-sampled HPV testing, with colposcopic immediate management of women positive for HPV, proved feasible in Nigeria. Based on the collected specimens and images, we are now evaluating the use of a combination of partial HPV typing and automated visual evaluation (AVE) of cervical images to improve the accuracy of the screening program.

Indexed as

Automated visual evaluationCervical screeningHPVSelf-samplingTriage

Identifiers

PMID33072178
PMCPMC7556552
OpenAlexW3093395961

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.